Virological outcome among HIV infected patients transferred from pediatric care to adult units in Madrid, Spain (1997–2017)

Fecha de publicación:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • Beltrán-Pavez C.
  • Gutiérrez-López M.
  • Rubio-Garrido M.
  • Valadés-Alcaraz A.
  • Ramos J.T.
  • Jiménez De Ory S.
  • Navarro M.
  • Díez-Romero C.
  • Pulido F.
  • Holguín Á.
  • Mellado M.J.
  • Escosa L.
  • García Hortelano M.
  • Sainz T.
  • González-Tomé M.I.
  • Rojo P.
  • Blázquez D.
  • Prieto-Tato L.
  • Epalza C.
  • Guillén S.
  • Navarro M.L.
  • Saavedra J.
  • Santos M.
  • Santiago B.
  • Aguilera-Alonso D.
  • Carrasco I.
  • Roa M.Á.
  • Penín M.
  • Martínez J.
  • Badillo K.
  • Oñate E.
  • Pocheville I.
  • Garrote E.
  • Colino E.
  • Gómez Sirvent J.
  • Garzón M.
  • Román V.
  • Angulo R.
  • Neth O.
  • Falcón L.
  • Terol P.
  • Santos J.L.
  • Moreno D.
  • Lendínez F.
  • Peromingo E.
  • Uberos J.
  • Ruiz B.
  • Grande A.
  • Romero F.J.
  • Pérez C.
  • Lillo M.
  • Losada B.
  • Herranz M.
  • Bustillo M.
  • Collado P.
  • Couceiro J.A.
  • Vila L.
  • Calviño C.
  • Oltra M.
  • Gavilán C.
  • Montesinos E.
  • Dapena M.
  • Álvarez C.
  • Jiménez B.
  • Andrés A.G.
  • Marugán V.
  • Ochoa C.
  • Alfayate S.
  • Menasalvas A.I.
  • Ruiz Del Prado Y.
  • Soler-Palacín P.
  • Frick M.A.
  • Mur A.
  • López N.
  • Méndez M.
  • Mayol L.
  • Vallmanya T.
  • Calavia O.
  • García L.
  • Coll M.T.
  • Pineda V.
  • Rius N.
  • Dueñas J.
  • Fortuny C.
  • Noguera-Julián A.
  • Bernardino I.
  • Montes M.L.
  • Valencia E.
  • Rubio R.
  • Bisbal O.
  • Gaspar Alonso G.
  • Berenguer J.
  • Díez C.
  • Aldamiz T.
  • Montilla P.
  • Bermúdez E.
  • Valerio M.
  • Arponen S.
  • Gimeno A.
  • Cervero M.
  • Torres R.
  • Moreno S.
  • Pérez M.ªJ.
  • Ryan P.
  • Troya J.
  • Sanz J.
  • Losa J.
  • Gómez R.
  • Iribarren J.A.
  • Rodríguez F.
  • Pascual L.
  • Aramburu M.J.
  • Goikoetxea A.J.
  • Aguirrebengoa L.
  • Muñoz J.
  • Ibarra S.
  • Hernández M.
  • Gómez Sirvent J.L.
  • Cárdenes M.Á.
  • López-Cortés L.F.
  • Roca C.
  • Llaves S.
  • Ríos M.J.
  • Rodríguez J.
  • Palomo V.
  • Pasquau J.
  • García C.
  • Hernández J.
  • Martínez C.
  • Rivero A.
  • Camacho Á.
  • Merino D.
  • Martínez E.
  • Mateos F.
  • Blanch J.J.
  • Torralba M.
  • Arazo P.
  • Samperiz G.
  • Crusells M.J.
  • San Joaquín I.
  • Miralles C.
  • Ocampo A.
  • Pousada G.
  • Mena Á.
  • Galindo M.J.
  • Ferrando R.
  • Portilla J.
  • Portilla I.
  • Gutiérrez F.
  • Masiá M.
  • Robledano C.
  • Adsuar A.
  • Hinojosa C.
  • Bachiller P.
  • Abadía J.
  • Mostaza J.L.
  • Pérez R.
  • Galera C.
  • Albendín H.
  • Pérez A.
  • Blanco J.R.
  • Burgos J.
  • Torres B.
  • Lazzari E.

Grupos

Abstract

The aim of this transversal study was to describe the virological and immunological features of HIV-infected youths transferred from pediatric to adult care units since 1997 vs. the non-transferred patients from the Madrid Cohort of HIV-infected children and adolescents in Spain. We included 106 non-transferred and 184 transferred patients under clinical follow-up in 17 public hospitals in Madrid by the end of December 2017. Virological and immunological outcomes were compared in transferred vs. non-transferred patients. ART drug resistance mutations and HIV-variants were analyzed in all subjects with available resistance pol genotypes and/or genotypic resistance profiles. Among the study cohort, 133 (72.3%) of 184 transferred and 75 (70.7%) of 106 non-transferred patients had available resistance genotypes. Most (88.9%) of transferred had ART experience at sampling. A third (33.3%) had had a triple-class experience. Acquired drug resistance (ADR) prevalence was significantly higher in pretreated transferred than non-transferred patients (71.8% vs. 44%; p = 0.0009), mainly to NRTI (72.8% vs. 31.1%; p < 0.0001) and PI (29.1% vs. 12%; p = 0.0262). HIV-1 non-B variants were less frequent in transferred vs. non-transferred (6.9% vs. 32%; p < 0.0001). In conclusion, the frequent resistant genotypes found in transferred youths justifies the reinforcement of HIV resistance monitoring after the transition to avoid future therapeutic failures. © 2020, The Author(s).

Datos de la publicación

ISSN/ISSNe:
2045-2322, 2045-2322

Scientific Reports  NATURE PORTFOLIO

Tipo:
Article
Páginas:
-
PubMed:
33037235
Enlace a otro recurso:
www.scopus.com
Factor de Impacto:
1,240 SCImago ℠
Cuartil:
Q1 SCImago ℠

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • Adolescent; Adult; Anti-HIV Agents; Child; Child, Preschool; Cohort Studies; Drug Resistance, Viral; Female; Genotype; HIV Infections; HIV-1; Humans; Infant; Male; Mutation; Pediatrics; Spain; Viral Load; Young Adult; anti human immunodeficiency virus agent; adolescent; adult; antiviral resistance; child; cohort analysis; drug effect; female; genetics; genotype; human; Human immunodeficiency virus 1; Human immunodeficiency virus infection; infant; male; mutation; pediatrics; preschool child; Spain; virology; virus load; young adult

Campos de Estudio

Cita

Compartir